Metro India News | Hyderabad 

In a major boost to AI-powered precision medicine, Hyderabad-based GenePoweRx has entered into a strategic co-marketing partnership on Wednesday with global life sciences innovator MGI Tech Co. Ltd. The collaboration aims to integrate advanced genomic sequencing with cutting-edge artificial intelligence to deliver fast, accurate, and personalized health solutions. 

Together, the two companies will work to democratize access to clinical-grade genomic services helping both individuals and healthcare providers take a more predictive and preventive approach to medicine. Speaking on the occasion, Dr. Kalyan Ram Uppaluri, Founder of GenePoweRx called the partnership a "game-changer" for the future of healthcare. He said that by aligning MGI’s state-of-the-art sequencing capabilities with GenePoweRx’s AI-powered genomics engine unmatched accuracy and speed can be offered and will help people make informed health decisions. 

Dr. Hima Jyothi Challa, MD, added that the partnership would significantly enhance the delivery of personalized and preventive care by enabling a shift from reactive treatment to proactive health management. Roy Tan, General Manager of MGI Asia Pacific, said the partnership aligns with MGI’s global mission to make precision healthcare widely accessible. He said that the partnership marks a strong step toward making personalized medicine a reality.

GenePoweRx is a healthtech company specialized in AI-powered genomic healthcare. It offers advanced genetic testing and risk analysis for over 100 chronic and lifestyle-related diseases including diabetes, cardiovascular disease, and hereditary cancers. 

MGI Tech Co. Ltd. is a life sciences company specializing in the development of gene sequencing technologies and multi-omics platforms. Founded in 2016, it serves customers globally with a full suite of digital instruments and reagents for healthcare, agriculture, and scientific research.